OUTCOMES |
Type of outcome
|
Outcome
|
Timepoint(s) at which outcome measured
|
Primary Outcome |
Depressive symptoms as assessed using the Patient Health Questionnaire-8 (PHQ-8). |
Participant will complete measures at baseline, 2 weeks, 4 weeks, and 12 weeks after study activities |
Primary Outcome |
Anxiety symptoms as assessed using the Generalized Anxiety Disorder Screener (GAD-7). |
Participant will complete measures at baseline, 2 weeks, 4 weeks, and 12 weeks after study activities |
Primary Outcome |
Subjective well-being as assessed using the Short Warwick-Edinburgh Mental Well-being Scale. |
Participant will complete measures at baseline, 2 weeks, 4 weeks, and 12 weeks after study activities. |
Secondary Outcome |
Acceptability (i.e., the extent to which a given treatment is agreeable or satisfactory) as assessed using the Acceptability of Intervention Measure (AIM) |
Participants will complete this after completing the study activities. |
Secondary Outcome |
Primary control (i.e., the extent to which individuals believe they can affect objective conditions in their lives, such as their grades or the actions of other people) as assessed using items from the perceived control scale for children (PCSC). |
Participant will complete measures at baseline, 2 weeks, 4 weeks, and 12 weeks after study activities. |
Secondary Outcome |
. Secondary control (i.e., the extent to which individuals believe that they can manage the personal and psychological impact of objective events) as assessed using items from the Secondary Control Scale for Children (SCSC |
Participant will complete measures at baseline, 2 weeks, 4 weeks, and 12 weeks after study activities. |